State of Healthtech in New York, NY 2026

8 funded Healthtech companies in New York, NY, backed most often by Andreessen Horowitz, Icon Ventures, Andreessen Horowitz.

Healthtech in New York, NY accounts for 35 tracked companies with verified cap-table data, 35 of which disclose round sizes totalling $6.7B. The median disclosed raise is $105M, and the largest is Ro at $1B, ahead of Abridge ($758M) and Judi Health ($607M).

The names that recur most often on these healthtech cap tables are General Catalyst (4 companies), Andreessen Horowitz (4 companies), Transformation Capital (4 companies), TCV (3 companies), Optum Ventures (3 companies), FirstMark Capital (2 companies). By latest disclosed round, the market skews Series C (11), Series B (9), Series D (7), Series A (4).

Best funded Healthtech in New York, NY companies

  1. Ro — $1B (latest: Series D)
  2. Abridge — $758M (latest: Series D)
  3. Judi Health — $607M (latest: Series F)
  4. K Health — $439M (latest: Series F)
  5. Maven Clinic — $425M (latest: Series D)
  6. Spring Health — $400M (latest: Series E)
  7. Grow Therapy — $225M (latest: Series D)
  8. Nitra — $205M (latest: Series B)
  9. Garner Health — $200M (latest: Series D)
  10. Nomad Health — $200M (latest: Series D)
  11. Unite Us — $195M (latest: Series C)
  12. Empathy — $162M (latest: Series C)
  13. Tennr — $162M (latest: Series C)
  14. Midi Health — $160M (latest: Series D)
  15. Vi Labs — $158M (latest: Growth)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library